Acamprosate Calcium is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Acamprosate Calcium.
| Product ID | 0093-5352_04f7b937-327d-4ba3-a61d-bfcd82ef5950 |
| NDC | 0093-5352 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Acamprosate Calcium |
| Generic Name | Acamprosate Calcium |
| Dosage Form | Tablet, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-03-25 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA200143 |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Substance Name | ACAMPROSATE CALCIUM |
| Active Ingredient Strength | 333 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-03-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA200143 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-03-25 |
| Ingredient | Strength |
|---|---|
| ACAMPROSATE CALCIUM | 333 mg/1 |
| SPL SET ID: | ca42a543-ae51-4386-9344-0c2d8e7da6f5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-5352 | Acamprosate Calcium | Acamprosate Calcium |
| 0378-6333 | Acamprosate Calcium | acamprosate calcium enteric-coated |
| 0904-7213 | Acamprosate Calcium | Acamprosate Calcium |
| 10135-636 | Acamprosate Calcium | Acamprosate Calcium |
| 42291-104 | Acamprosate Calcium | Acamprosate Calcium |
| 51079-241 | Acamprosate Calcium | acamprosate calcium enteric-coated |
| 60687-121 | Acamprosate Calcium | Acamprosate Calcium |
| 68382-569 | acamprosate calcium | acamprosate calcium |
| 68462-435 | Acamprosate Calcium | Acamprosate Calcium |
| 70771-1057 | acamprosate calcium | acamprosate calcium |
| 68151-4760 | Campral | acamprosate calcium |